Brief: Endra Provides Update Following In-Person Meeting With FDA
May 20 (Reuters) - ENDRA Life Sciences Inc NDRA.O :
* ENDRA PROVIDES UPDATE FOLLOWING IN-PERSON MEETING WITH FDA
* ENDRA LIFE SCIENCES INC - INCREASES CLARITY FOR ENDRA ON
REGULATORY PATH FORWARD FOR TAEUS
Source text for Eikon: ID:nBwbFY146a
Further company coverage: NDRA.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences